UK markets closed

UniPharma Co., Ltd. (6621.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
13.10+0.75 (+6.07%)
At close: 02:59PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
103,222
103,222
128,107
105,387
138,635
Cost of revenue
52,206
52,206
53,488
46,062
69,319
Gross profit
51,016
51,016
74,619
59,325
69,316
Operating expenses
Research development
17,834
17,834
26,318
33,047
24,858
Selling general and administrative
60,487
60,487
69,177
66,499
65,072
Total operating expenses
78,321
78,321
95,495
99,546
89,930
Operating income or loss
-27,305
-27,305
-20,876
-40,221
-20,614
Interest expense
14
14
39
99
141
Income before tax
-21,813
-21,813
-7,027
-74,406
-55,351
Income tax expense
0
0
0
0
0
Income from continuing operations
-21,813
-21,813
-7,027
-74,406
-55,351
Net income
-21,813
-21,813
-6,446
-74,406
-55,351
Net income available to common shareholders
-21,813
-21,813
-6,446
-74,406
-55,351
Basic EPS
-0.40
-
-0.18
-2.11
-1.57
Diluted EPS
-0.40
-
-0.18
-2.11
-1.57
Basic average shares
35,502
-
35,811
35,201
35,201
Diluted average shares
35,502
-
35,811
35,201
35,201